Latest Amgen Stories
THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of Steven K.
Amgen Is Building World's Largest Cancer Support Team THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ -- Amgen today announced that four individuals who are an inspiration for others
SANTA MONICA, Calif., May 12, 2014 /PRNewswire/ -- Kite Pharma, Inc.
Study Evaluating Novel Investigational IL-17 Receptor Antibody Meets All Primary and Secondary Endpoints THOUSAND OAKS, Calif.
Cycling Fans Gain Unprecedented Access to All of the Action from the Peloton and Beyond via the Amgen Tour of California Social Hub Presented by Visit California
OXFORD, England and SAN JOSE, May 7, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug
THOUSAND OAKS, Calif., May 2, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Deutsche Bank 39(th) Annual Healthcare Conference at 2:50 p.m.
CHICAGO, May 1, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.